Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $10.20 million. The enterprise value is -$3.80 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 11.45 million shares outstanding. The number of shares has increased by 18.67% in one year.
| Current Share Class | 11.45M |
| Shares Outstanding | 11.45M |
| Shares Change (YoY) | +18.67% |
| Shares Change (QoQ) | +20.63% |
| Owned by Insiders (%) | 12.23% |
| Owned by Institutions (%) | 14.82% |
| Float | 8.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 37.79 |
| Forward PS | n/a |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.63
| Current Ratio | 5.63 |
| Quick Ratio | 5.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -74.58% and return on invested capital (ROIC) is -48.96%.
| Return on Equity (ROE) | -74.58% |
| Return on Assets (ROA) | -41.45% |
| Return on Invested Capital (ROIC) | -48.96% |
| Return on Capital Employed (ROCE) | -100.49% |
| Weighted Average Cost of Capital (WACC) | 12.91% |
| Revenue Per Employee | $35,720 |
| Profits Per Employee | -$1.57M |
| Employee Count | 8 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.91% in the last 52 weeks. The beta is 1.57, so APRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -41.91% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 61.41 |
| Average Volume (20 Days) | 747,363 |
Short Selling Information
The latest short interest is 640,347, so 5.59% of the outstanding shares have been sold short.
| Short Interest | 640,347 |
| Short Previous Month | 106,655 |
| Short % of Shares Out | 5.59% |
| Short % of Float | 7.29% |
| Short Ratio (days to cover) | 0.29 |
Income Statement
In the last 12 months, APRE had revenue of $285,759 and -$12.60 million in losses. Loss per share was -$1.93.
| Revenue | 285,759 |
| Gross Profit | -6.76M |
| Operating Income | -13.23M |
| Pretax Income | -12.60M |
| Net Income | -12.60M |
| EBITDA | -13.21M |
| EBIT | -13.23M |
| Loss Per Share | -$1.93 |
Full Income StatementBalance Sheet
The company has $14.60 million in cash and n/a in debt, with a net cash position of $14.60 million or $1.27 per share.
| Cash & Cash Equivalents | 14.60M |
| Total Debt | n/a |
| Net Cash | 14.60M |
| Net Cash Per Share | $1.27 |
| Equity (Book Value) | 13.17M |
| Book Value Per Share | 1.52 |
| Working Capital | 12.80M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.89M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 21,715 |
| Net Borrowing | n/a |
| Free Cash Flow | -12.89M |
| FCF Per Share | -$1.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -4,631.12% |
| Pretax Margin | -4,409.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.67% |
| Shareholder Yield | -18.67% |
| Earnings Yield | -116.67% |
| FCF Yield | -119.40% |
Analyst Forecast
The average price target for APRE is $4.10, which is 360.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.10 |
| Price Target Difference | 360.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 235.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
APRE has an Altman Z-Score of -28.75. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.75 |
| Piotroski F-Score | n/a |
